Global Critical Illness Insurance

Critical Illness Insurance Comprehensive Study by Type (Disease Insurance, Medical Insurance, Income Protection Insurance), Application (Heart attack, Life-threatening cancer, Loss of hearing, Loss of speech, Loss of vision, Major organ transplant, Paralysis, Coma, Renal failure, Stroke, Carcinoma in situ, Coronary artery bypass graft, Others), Policy Type (Standalone, Rider {Additional Benefit, Accelerated Benefit}), Premium Mode (Monthly, Quarterly, Half Yearly, Yearly), Age Group (0-19 Years, 20-29 Years, 30-39 Years, 40-49 Years, 50-59 Years, 60+ Years), Gender (Male, Female), Provider (Life Insurance, Health Insurance) Players and Region - Global Market Outlook to 2028

Critical Illness Insurance Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Critical Illness Insurance Market Scope?
Critical illness insurance is also known as dread disease policy or critical illness cover. It is an insurance product in which the insurer is contracted to usually make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy. The policy may also be structured to pay out regular income and the payout may also be on the policyholder undergoing a surgical procedure, for e.g., having a heart bypasses operation. According to the U.S. Department of Health & Human Services, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 37 seconds in the United States from cardiovascular disease. About 647,000 Americans die from heart disease each year—that’s 1 in every 4 deaths. Heart disease costs the United States about USD 219 billion each year from 2014 to 2015. This includes the cost of medicines, health care services, and lost productivity due to death.

Influencing Trend:
Rapid Adoption of Machine Learning and AI Technology

Market Growth Drivers:
Increasing Risk of Falling Prey to Life-Style Diseases and The Rapidly Growing Medical Expenses

Restraints:
An Availability of Alternative Insurance Coverage

Opportunities:
The Emerging Demand from the Developing Countries

The Critical Illness Insurance market study is being classified by Type (Disease Insurance, Medical Insurance and Income Protection Insurance), by Application and major geographies with country level break-up.

The companies are determining this industry across new geographical areas by accepting numerous strategic growth areas such as mergers & acquisitions, expansions, investments, new product launches and others. The market key players are exploring new areas through growths and achievements across the globe to benefit from competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States and Chinese will contribute to the maximum growth of Global Critical Illness Insurance market throughout the predicted period.

China Life Insurance Company (China), Ping An Insurance (China), China Pacific Insurance (China), Aviva (United Kingdom), Legal & General (United Kingdom), New China Life Insurance (China), AXA (France), Prudential plc (United Kingdom), Aegon NV (Netherland), Allianz SE (Germany), AIG (United States), UnitedHealthcare Group (United States), Zurich Insurance Group (Switzerland), MetLife (United States) and Dai-ichi Life Group (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Huaxia life Insurance (China), Aflac (United States), Liberty Mutual (United States), HCF (Australia), Religare (India), Reliance (India), Manipalcigna Health Insurance Company (India), Edelwiess (India) and ICICI Prudential Life Insurance Co. Ltd. (India).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Critical Illness Insurance market by Type, Application and Region.

On the basis of geography, the market of Critical Illness Insurance has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
On 27 Nov 2019, AXA Insurance announced the launch of AXA Super CritiCare, a critical illness plan designed to provide all-rounded protection including multiple payouts for early, intermediate and advanced stage critical illnesses up to a total of 600% of the coverage amount, as well as support for customers to take control of their health and well-being with a diabetes management programme, which is the only such offering provided by an insurer.
On 26 Nov 2018, Legal & General has announced a range of updates across its Critical Illness Cover (CIC), to their Critical Illness Extra (CIx) and Children’s Critical Illness Extra (CCIx) offering. Updates include increasing additional payments for CIx to 25% of the sum assured up to a maximum of £30,000, and CCIx to 50% of the sum assured, up to a maximum of £30,000. As well as improving their definitions for heart attack and dementia, and added craniosynostosis to the list of conditions covered under CCIx. and On 10 Sept 2018, Bajaj Allianz Life has entered into the health insurance segment by launching Nationally a critical illness cover 'Bajaj Allianz Life Health Care Goal'. Under this plan, a family of up to 6 members can be covered under one policy in one premium and it covers 36 critical illnesses, including deafness, heart valve surgery and kidney failure requiring regular dialysis, Company CEO and Managing Director Tarun Chugh said at a press conference on the occasion.


Key Target Audience
Critical Insurance Providers, Regulatory & Government Bodies, Downstream & Upstream Vendors, End Users and Others

Critical Illness Insurance Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Critical Illness Insurance Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Critical Illness Insurance industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Disease Insurance
  • Medical Insurance
  • Income Protection Insurance
By Application
  • Heart attack
  • Life-threatening cancer
  • Loss of hearing
  • Loss of speech
  • Loss of vision
  • Major organ transplant
  • Paralysis
  • Coma
  • Renal failure
  • Stroke
  • Carcinoma in situ
  • Coronary artery bypass graft
  • Others
By Policy Type
  • Standalone
  • Rider {Additional Benefit, Accelerated Benefit}

By Premium Mode
  • Monthly
  • Quarterly
  • Half Yearly
  • Yearly

By Age Group
  • 0-19 Years
  • 20-29 Years
  • 30-39 Years
  • 40-49 Years
  • 50-59 Years
  • 60+ Years

By Gender
  • Male
  • Female

By Provider
  • Life Insurance
  • Health Insurance

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Risk of Falling Prey to Life-Style Diseases
      • 3.2.2. The Rapidly Growing Medical Expenses
    • 3.3. Market Trends
      • 3.3.1. Rapid Adoption of Machine Learning and AI Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Critical Illness Insurance, by Type, Application, Policy Type, Premium Mode, Age Group, Gender, Provider and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Critical Illness Insurance (Value)
      • 5.2.1. Global Critical Illness Insurance by: Type (Value)
        • 5.2.1.1. Disease Insurance
        • 5.2.1.2. Medical Insurance
        • 5.2.1.3. Income Protection Insurance
      • 5.2.2. Global Critical Illness Insurance by: Application (Value)
        • 5.2.2.1. Heart attack
        • 5.2.2.2. Life-threatening cancer
        • 5.2.2.3. Loss of hearing
        • 5.2.2.4. Loss of speech
        • 5.2.2.5. Loss of vision
        • 5.2.2.6. Major organ transplant
        • 5.2.2.7. Paralysis
        • 5.2.2.8. Coma
        • 5.2.2.9. Renal failure
        • 5.2.2.10. Stroke
        • 5.2.2.11. Carcinoma in situ
        • 5.2.2.12. Coronary artery bypass graft
        • 5.2.2.13. Others
      • 5.2.3. Global Critical Illness Insurance by: Policy Type (Value)
        • 5.2.3.1. Standalone
        • 5.2.3.2. Rider {Additional Benefit, Accelerated Benefit}
      • 5.2.4. Global Critical Illness Insurance by: Premium Mode (Value)
        • 5.2.4.1. Monthly
        • 5.2.4.2. Quarterly
        • 5.2.4.3. Half Yearly
        • 5.2.4.4. Yearly
      • 5.2.5. Global Critical Illness Insurance by: Age Group (Value)
        • 5.2.5.1. 0-19 Years
        • 5.2.5.2. 20-29 Years
        • 5.2.5.3. 30-39 Years
        • 5.2.5.4. 40-49 Years
        • 5.2.5.5. 50-59 Years
        • 5.2.5.6. 60+ Years
      • 5.2.6. Global Critical Illness Insurance by: Gender (Value)
        • 5.2.6.1. Male
        • 5.2.6.2. Female
      • 5.2.7. Global Critical Illness Insurance by: Provider (Value)
        • 5.2.7.1. Life Insurance
        • 5.2.7.2. Health Insurance
      • 5.2.8. Global Critical Illness Insurance Region
        • 5.2.8.1. South America
          • 5.2.8.1.1. Brazil
          • 5.2.8.1.2. Argentina
          • 5.2.8.1.3. Rest of South America
        • 5.2.8.2. Asia Pacific
          • 5.2.8.2.1. China
          • 5.2.8.2.2. Japan
          • 5.2.8.2.3. India
          • 5.2.8.2.4. South Korea
          • 5.2.8.2.5. Taiwan
          • 5.2.8.2.6. Australia
          • 5.2.8.2.7. Rest of Asia-Pacific
        • 5.2.8.3. Europe
          • 5.2.8.3.1. Germany
          • 5.2.8.3.2. France
          • 5.2.8.3.3. Italy
          • 5.2.8.3.4. United Kingdom
          • 5.2.8.3.5. Netherlands
          • 5.2.8.3.6. Rest of Europe
        • 5.2.8.4. MEA
          • 5.2.8.4.1. Middle East
          • 5.2.8.4.2. Africa
        • 5.2.8.5. North America
          • 5.2.8.5.1. United States
          • 5.2.8.5.2. Canada
          • 5.2.8.5.3. Mexico
  • 6. Critical Illness Insurance: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. China Life Insurance Company (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ping An Insurance (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. China Pacific Insurance (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aviva (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Legal & General (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. New China Life Insurance (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AXA (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Prudential plc (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aegon NV (Netherland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Allianz SE (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. AIG (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. UnitedHealthcare Group (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Zurich Insurance Group (Switzerland)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. MetLife (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Dai-ichi Life Group (Japan)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Critical Illness Insurance Sale, by Type, Application, Policy Type, Premium Mode, Age Group, Gender, Provider and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Critical Illness Insurance (Value)
      • 7.2.1. Global Critical Illness Insurance by: Type (Value)
        • 7.2.1.1. Disease Insurance
        • 7.2.1.2. Medical Insurance
        • 7.2.1.3. Income Protection Insurance
      • 7.2.2. Global Critical Illness Insurance by: Application (Value)
        • 7.2.2.1. Heart attack
        • 7.2.2.2. Life-threatening cancer
        • 7.2.2.3. Loss of hearing
        • 7.2.2.4. Loss of speech
        • 7.2.2.5. Loss of vision
        • 7.2.2.6. Major organ transplant
        • 7.2.2.7. Paralysis
        • 7.2.2.8. Coma
        • 7.2.2.9. Renal failure
        • 7.2.2.10. Stroke
        • 7.2.2.11. Carcinoma in situ
        • 7.2.2.12. Coronary artery bypass graft
        • 7.2.2.13. Others
      • 7.2.3. Global Critical Illness Insurance by: Policy Type (Value)
        • 7.2.3.1. Standalone
        • 7.2.3.2. Rider {Additional Benefit, Accelerated Benefit}
      • 7.2.4. Global Critical Illness Insurance by: Premium Mode (Value)
        • 7.2.4.1. Monthly
        • 7.2.4.2. Quarterly
        • 7.2.4.3. Half Yearly
        • 7.2.4.4. Yearly
      • 7.2.5. Global Critical Illness Insurance by: Age Group (Value)
        • 7.2.5.1. 0-19 Years
        • 7.2.5.2. 20-29 Years
        • 7.2.5.3. 30-39 Years
        • 7.2.5.4. 40-49 Years
        • 7.2.5.5. 50-59 Years
        • 7.2.5.6. 60+ Years
      • 7.2.6. Global Critical Illness Insurance by: Gender (Value)
        • 7.2.6.1. Male
        • 7.2.6.2. Female
      • 7.2.7. Global Critical Illness Insurance by: Provider (Value)
        • 7.2.7.1. Life Insurance
        • 7.2.7.2. Health Insurance
      • 7.2.8. Global Critical Illness Insurance Region
        • 7.2.8.1. South America
          • 7.2.8.1.1. Brazil
          • 7.2.8.1.2. Argentina
          • 7.2.8.1.3. Rest of South America
        • 7.2.8.2. Asia Pacific
          • 7.2.8.2.1. China
          • 7.2.8.2.2. Japan
          • 7.2.8.2.3. India
          • 7.2.8.2.4. South Korea
          • 7.2.8.2.5. Taiwan
          • 7.2.8.2.6. Australia
          • 7.2.8.2.7. Rest of Asia-Pacific
        • 7.2.8.3. Europe
          • 7.2.8.3.1. Germany
          • 7.2.8.3.2. France
          • 7.2.8.3.3. Italy
          • 7.2.8.3.4. United Kingdom
          • 7.2.8.3.5. Netherlands
          • 7.2.8.3.6. Rest of Europe
        • 7.2.8.4. MEA
          • 7.2.8.4.1. Middle East
          • 7.2.8.4.2. Africa
        • 7.2.8.5. North America
          • 7.2.8.5.1. United States
          • 7.2.8.5.2. Canada
          • 7.2.8.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Critical Illness Insurance: by Type(USD Million)
  • Table 2. Critical Illness Insurance Disease Insurance , by Region USD Million (2017-2022)
  • Table 3. Critical Illness Insurance Medical Insurance , by Region USD Million (2017-2022)
  • Table 4. Critical Illness Insurance Income Protection Insurance , by Region USD Million (2017-2022)
  • Table 5. Critical Illness Insurance: by Application(USD Million)
  • Table 6. Critical Illness Insurance Heart attack , by Region USD Million (2017-2022)
  • Table 7. Critical Illness Insurance Life-threatening cancer , by Region USD Million (2017-2022)
  • Table 8. Critical Illness Insurance Loss of hearing , by Region USD Million (2017-2022)
  • Table 9. Critical Illness Insurance Loss of speech , by Region USD Million (2017-2022)
  • Table 10. Critical Illness Insurance Loss of vision , by Region USD Million (2017-2022)
  • Table 11. Critical Illness Insurance Major organ transplant , by Region USD Million (2017-2022)
  • Table 12. Critical Illness Insurance Paralysis , by Region USD Million (2017-2022)
  • Table 13. Critical Illness Insurance Coma , by Region USD Million (2017-2022)
  • Table 14. Critical Illness Insurance Renal failure , by Region USD Million (2017-2022)
  • Table 15. Critical Illness Insurance Stroke , by Region USD Million (2017-2022)
  • Table 16. Critical Illness Insurance Carcinoma in situ , by Region USD Million (2017-2022)
  • Table 17. Critical Illness Insurance Coronary artery bypass graft , by Region USD Million (2017-2022)
  • Table 18. Critical Illness Insurance Others , by Region USD Million (2017-2022)
  • Table 19. Critical Illness Insurance: by Policy Type(USD Million)
  • Table 20. Critical Illness Insurance Standalone , by Region USD Million (2017-2022)
  • Table 21. Critical Illness Insurance Rider {Additional Benefit, Accelerated Benefit} , by Region USD Million (2017-2022)
  • Table 22. Critical Illness Insurance: by Premium Mode(USD Million)
  • Table 23. Critical Illness Insurance Monthly , by Region USD Million (2017-2022)
  • Table 24. Critical Illness Insurance Quarterly , by Region USD Million (2017-2022)
  • Table 25. Critical Illness Insurance Half Yearly , by Region USD Million (2017-2022)
  • Table 26. Critical Illness Insurance Yearly , by Region USD Million (2017-2022)
  • Table 27. Critical Illness Insurance: by Age Group(USD Million)
  • Table 28. Critical Illness Insurance 0-19 Years , by Region USD Million (2017-2022)
  • Table 29. Critical Illness Insurance 20-29 Years , by Region USD Million (2017-2022)
  • Table 30. Critical Illness Insurance 30-39 Years , by Region USD Million (2017-2022)
  • Table 31. Critical Illness Insurance 40-49 Years , by Region USD Million (2017-2022)
  • Table 32. Critical Illness Insurance 50-59 Years , by Region USD Million (2017-2022)
  • Table 33. Critical Illness Insurance 60+ Years , by Region USD Million (2017-2022)
  • Table 34. Critical Illness Insurance: by Gender(USD Million)
  • Table 35. Critical Illness Insurance Male , by Region USD Million (2017-2022)
  • Table 36. Critical Illness Insurance Female , by Region USD Million (2017-2022)
  • Table 37. Critical Illness Insurance: by Provider(USD Million)
  • Table 38. Critical Illness Insurance Life Insurance , by Region USD Million (2017-2022)
  • Table 39. Critical Illness Insurance Health Insurance , by Region USD Million (2017-2022)
  • Table 40. South America Critical Illness Insurance, by Country USD Million (2017-2022)
  • Table 41. South America Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 42. South America Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 43. South America Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 44. South America Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 45. South America Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 46. South America Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 47. South America Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 48. Brazil Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 49. Brazil Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 50. Brazil Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 51. Brazil Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 52. Brazil Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 53. Brazil Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 54. Brazil Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 55. Argentina Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 56. Argentina Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 57. Argentina Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 58. Argentina Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 59. Argentina Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 60. Argentina Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 61. Argentina Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 62. Rest of South America Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 63. Rest of South America Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 64. Rest of South America Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 65. Rest of South America Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 66. Rest of South America Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 67. Rest of South America Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 68. Rest of South America Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 69. Asia Pacific Critical Illness Insurance, by Country USD Million (2017-2022)
  • Table 70. Asia Pacific Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 71. Asia Pacific Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 72. Asia Pacific Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 73. Asia Pacific Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 74. Asia Pacific Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 75. Asia Pacific Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 76. Asia Pacific Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 77. China Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 78. China Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 79. China Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 80. China Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 81. China Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 82. China Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 83. China Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 84. Japan Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 85. Japan Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 86. Japan Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 87. Japan Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 88. Japan Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 89. Japan Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 90. Japan Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 91. India Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 92. India Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 93. India Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 94. India Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 95. India Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 96. India Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 97. India Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 98. South Korea Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 99. South Korea Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 100. South Korea Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 101. South Korea Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 102. South Korea Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 103. South Korea Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 104. South Korea Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 105. Taiwan Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 106. Taiwan Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 107. Taiwan Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 108. Taiwan Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 109. Taiwan Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 110. Taiwan Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 111. Taiwan Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 112. Australia Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 113. Australia Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 114. Australia Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 115. Australia Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 116. Australia Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 117. Australia Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 118. Australia Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 119. Rest of Asia-Pacific Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 120. Rest of Asia-Pacific Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 121. Rest of Asia-Pacific Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 122. Rest of Asia-Pacific Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 123. Rest of Asia-Pacific Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 124. Rest of Asia-Pacific Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 125. Rest of Asia-Pacific Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 126. Europe Critical Illness Insurance, by Country USD Million (2017-2022)
  • Table 127. Europe Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 128. Europe Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 129. Europe Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 130. Europe Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 131. Europe Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 132. Europe Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 133. Europe Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 134. Germany Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 135. Germany Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 136. Germany Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 137. Germany Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 138. Germany Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 139. Germany Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 140. Germany Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 141. France Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 142. France Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 143. France Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 144. France Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 145. France Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 146. France Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 147. France Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 148. Italy Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 149. Italy Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 150. Italy Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 151. Italy Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 152. Italy Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 153. Italy Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 154. Italy Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 155. United Kingdom Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 156. United Kingdom Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 157. United Kingdom Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 158. United Kingdom Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 159. United Kingdom Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 160. United Kingdom Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 161. United Kingdom Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 162. Netherlands Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 163. Netherlands Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 164. Netherlands Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 165. Netherlands Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 166. Netherlands Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 167. Netherlands Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 168. Netherlands Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 169. Rest of Europe Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 170. Rest of Europe Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 171. Rest of Europe Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 172. Rest of Europe Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 173. Rest of Europe Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 174. Rest of Europe Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 175. Rest of Europe Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 176. MEA Critical Illness Insurance, by Country USD Million (2017-2022)
  • Table 177. MEA Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 178. MEA Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 179. MEA Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 180. MEA Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 181. MEA Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 182. MEA Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 183. MEA Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 184. Middle East Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 185. Middle East Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 186. Middle East Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 187. Middle East Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 188. Middle East Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 189. Middle East Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 190. Middle East Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 191. Africa Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 192. Africa Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 193. Africa Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 194. Africa Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 195. Africa Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 196. Africa Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 197. Africa Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 198. North America Critical Illness Insurance, by Country USD Million (2017-2022)
  • Table 199. North America Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 200. North America Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 201. North America Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 202. North America Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 203. North America Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 204. North America Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 205. North America Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 206. United States Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 207. United States Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 208. United States Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 209. United States Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 210. United States Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 211. United States Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 212. United States Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 213. Canada Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 214. Canada Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 215. Canada Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 216. Canada Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 217. Canada Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 218. Canada Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 219. Canada Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 220. Mexico Critical Illness Insurance, by Type USD Million (2017-2022)
  • Table 221. Mexico Critical Illness Insurance, by Application USD Million (2017-2022)
  • Table 222. Mexico Critical Illness Insurance, by Policy Type USD Million (2017-2022)
  • Table 223. Mexico Critical Illness Insurance, by Premium Mode USD Million (2017-2022)
  • Table 224. Mexico Critical Illness Insurance, by Age Group USD Million (2017-2022)
  • Table 225. Mexico Critical Illness Insurance, by Gender USD Million (2017-2022)
  • Table 226. Mexico Critical Illness Insurance, by Provider USD Million (2017-2022)
  • Table 227. Company Basic Information, Sales Area and Its Competitors
  • Table 228. Company Basic Information, Sales Area and Its Competitors
  • Table 229. Company Basic Information, Sales Area and Its Competitors
  • Table 230. Company Basic Information, Sales Area and Its Competitors
  • Table 231. Company Basic Information, Sales Area and Its Competitors
  • Table 232. Company Basic Information, Sales Area and Its Competitors
  • Table 233. Company Basic Information, Sales Area and Its Competitors
  • Table 234. Company Basic Information, Sales Area and Its Competitors
  • Table 235. Company Basic Information, Sales Area and Its Competitors
  • Table 236. Company Basic Information, Sales Area and Its Competitors
  • Table 237. Company Basic Information, Sales Area and Its Competitors
  • Table 238. Company Basic Information, Sales Area and Its Competitors
  • Table 239. Company Basic Information, Sales Area and Its Competitors
  • Table 240. Company Basic Information, Sales Area and Its Competitors
  • Table 241. Company Basic Information, Sales Area and Its Competitors
  • Table 242. Critical Illness Insurance: by Type(USD Million)
  • Table 243. Critical Illness Insurance Disease Insurance , by Region USD Million (2023-2028)
  • Table 244. Critical Illness Insurance Medical Insurance , by Region USD Million (2023-2028)
  • Table 245. Critical Illness Insurance Income Protection Insurance , by Region USD Million (2023-2028)
  • Table 246. Critical Illness Insurance: by Application(USD Million)
  • Table 247. Critical Illness Insurance Heart attack , by Region USD Million (2023-2028)
  • Table 248. Critical Illness Insurance Life-threatening cancer , by Region USD Million (2023-2028)
  • Table 249. Critical Illness Insurance Loss of hearing , by Region USD Million (2023-2028)
  • Table 250. Critical Illness Insurance Loss of speech , by Region USD Million (2023-2028)
  • Table 251. Critical Illness Insurance Loss of vision , by Region USD Million (2023-2028)
  • Table 252. Critical Illness Insurance Major organ transplant , by Region USD Million (2023-2028)
  • Table 253. Critical Illness Insurance Paralysis , by Region USD Million (2023-2028)
  • Table 254. Critical Illness Insurance Coma , by Region USD Million (2023-2028)
  • Table 255. Critical Illness Insurance Renal failure , by Region USD Million (2023-2028)
  • Table 256. Critical Illness Insurance Stroke , by Region USD Million (2023-2028)
  • Table 257. Critical Illness Insurance Carcinoma in situ , by Region USD Million (2023-2028)
  • Table 258. Critical Illness Insurance Coronary artery bypass graft , by Region USD Million (2023-2028)
  • Table 259. Critical Illness Insurance Others , by Region USD Million (2023-2028)
  • Table 260. Critical Illness Insurance: by Policy Type(USD Million)
  • Table 261. Critical Illness Insurance Standalone , by Region USD Million (2023-2028)
  • Table 262. Critical Illness Insurance Rider {Additional Benefit, Accelerated Benefit} , by Region USD Million (2023-2028)
  • Table 263. Critical Illness Insurance: by Premium Mode(USD Million)
  • Table 264. Critical Illness Insurance Monthly , by Region USD Million (2023-2028)
  • Table 265. Critical Illness Insurance Quarterly , by Region USD Million (2023-2028)
  • Table 266. Critical Illness Insurance Half Yearly , by Region USD Million (2023-2028)
  • Table 267. Critical Illness Insurance Yearly , by Region USD Million (2023-2028)
  • Table 268. Critical Illness Insurance: by Age Group(USD Million)
  • Table 269. Critical Illness Insurance 0-19 Years , by Region USD Million (2023-2028)
  • Table 270. Critical Illness Insurance 20-29 Years , by Region USD Million (2023-2028)
  • Table 271. Critical Illness Insurance 30-39 Years , by Region USD Million (2023-2028)
  • Table 272. Critical Illness Insurance 40-49 Years , by Region USD Million (2023-2028)
  • Table 273. Critical Illness Insurance 50-59 Years , by Region USD Million (2023-2028)
  • Table 274. Critical Illness Insurance 60+ Years , by Region USD Million (2023-2028)
  • Table 275. Critical Illness Insurance: by Gender(USD Million)
  • Table 276. Critical Illness Insurance Male , by Region USD Million (2023-2028)
  • Table 277. Critical Illness Insurance Female , by Region USD Million (2023-2028)
  • Table 278. Critical Illness Insurance: by Provider(USD Million)
  • Table 279. Critical Illness Insurance Life Insurance , by Region USD Million (2023-2028)
  • Table 280. Critical Illness Insurance Health Insurance , by Region USD Million (2023-2028)
  • Table 281. South America Critical Illness Insurance, by Country USD Million (2023-2028)
  • Table 282. South America Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 283. South America Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 284. South America Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 285. South America Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 286. South America Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 287. South America Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 288. South America Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 289. Brazil Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 290. Brazil Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 291. Brazil Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 292. Brazil Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 293. Brazil Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 294. Brazil Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 295. Brazil Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 296. Argentina Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 297. Argentina Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 298. Argentina Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 299. Argentina Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 300. Argentina Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 301. Argentina Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 302. Argentina Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 303. Rest of South America Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 304. Rest of South America Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 305. Rest of South America Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 306. Rest of South America Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 307. Rest of South America Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 308. Rest of South America Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 309. Rest of South America Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 310. Asia Pacific Critical Illness Insurance, by Country USD Million (2023-2028)
  • Table 311. Asia Pacific Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 312. Asia Pacific Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 313. Asia Pacific Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 314. Asia Pacific Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 315. Asia Pacific Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 316. Asia Pacific Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 317. Asia Pacific Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 318. China Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 319. China Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 320. China Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 321. China Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 322. China Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 323. China Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 324. China Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 325. Japan Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 326. Japan Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 327. Japan Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 328. Japan Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 329. Japan Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 330. Japan Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 331. Japan Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 332. India Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 333. India Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 334. India Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 335. India Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 336. India Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 337. India Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 338. India Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 339. South Korea Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 340. South Korea Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 341. South Korea Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 342. South Korea Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 343. South Korea Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 344. South Korea Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 345. South Korea Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 346. Taiwan Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 347. Taiwan Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 348. Taiwan Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 349. Taiwan Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 350. Taiwan Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 351. Taiwan Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 352. Taiwan Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 353. Australia Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 354. Australia Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 355. Australia Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 356. Australia Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 357. Australia Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 358. Australia Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 359. Australia Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 360. Rest of Asia-Pacific Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 361. Rest of Asia-Pacific Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 362. Rest of Asia-Pacific Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 363. Rest of Asia-Pacific Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 364. Rest of Asia-Pacific Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 365. Rest of Asia-Pacific Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 366. Rest of Asia-Pacific Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 367. Europe Critical Illness Insurance, by Country USD Million (2023-2028)
  • Table 368. Europe Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 369. Europe Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 370. Europe Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 371. Europe Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 372. Europe Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 373. Europe Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 374. Europe Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 375. Germany Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 376. Germany Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 377. Germany Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 378. Germany Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 379. Germany Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 380. Germany Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 381. Germany Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 382. France Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 383. France Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 384. France Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 385. France Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 386. France Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 387. France Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 388. France Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 389. Italy Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 390. Italy Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 391. Italy Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 392. Italy Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 393. Italy Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 394. Italy Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 395. Italy Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 396. United Kingdom Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 397. United Kingdom Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 398. United Kingdom Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 399. United Kingdom Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 400. United Kingdom Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 401. United Kingdom Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 402. United Kingdom Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 403. Netherlands Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 404. Netherlands Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 405. Netherlands Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 406. Netherlands Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 407. Netherlands Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 408. Netherlands Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 409. Netherlands Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 410. Rest of Europe Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 411. Rest of Europe Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 412. Rest of Europe Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 413. Rest of Europe Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 414. Rest of Europe Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 415. Rest of Europe Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 416. Rest of Europe Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 417. MEA Critical Illness Insurance, by Country USD Million (2023-2028)
  • Table 418. MEA Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 419. MEA Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 420. MEA Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 421. MEA Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 422. MEA Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 423. MEA Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 424. MEA Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 425. Middle East Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 426. Middle East Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 427. Middle East Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 428. Middle East Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 429. Middle East Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 430. Middle East Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 431. Middle East Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 432. Africa Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 433. Africa Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 434. Africa Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 435. Africa Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 436. Africa Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 437. Africa Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 438. Africa Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 439. North America Critical Illness Insurance, by Country USD Million (2023-2028)
  • Table 440. North America Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 441. North America Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 442. North America Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 443. North America Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 444. North America Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 445. North America Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 446. North America Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 447. United States Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 448. United States Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 449. United States Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 450. United States Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 451. United States Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 452. United States Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 453. United States Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 454. Canada Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 455. Canada Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 456. Canada Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 457. Canada Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 458. Canada Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 459. Canada Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 460. Canada Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 461. Mexico Critical Illness Insurance, by Type USD Million (2023-2028)
  • Table 462. Mexico Critical Illness Insurance, by Application USD Million (2023-2028)
  • Table 463. Mexico Critical Illness Insurance, by Policy Type USD Million (2023-2028)
  • Table 464. Mexico Critical Illness Insurance, by Premium Mode USD Million (2023-2028)
  • Table 465. Mexico Critical Illness Insurance, by Age Group USD Million (2023-2028)
  • Table 466. Mexico Critical Illness Insurance, by Gender USD Million (2023-2028)
  • Table 467. Mexico Critical Illness Insurance, by Provider USD Million (2023-2028)
  • Table 468. Research Programs/Design for This Report
  • Table 469. Key Data Information from Secondary Sources
  • Table 470. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Critical Illness Insurance: by Type USD Million (2017-2022)
  • Figure 5. Global Critical Illness Insurance: by Application USD Million (2017-2022)
  • Figure 6. Global Critical Illness Insurance: by Policy Type USD Million (2017-2022)
  • Figure 7. Global Critical Illness Insurance: by Premium Mode USD Million (2017-2022)
  • Figure 8. Global Critical Illness Insurance: by Age Group USD Million (2017-2022)
  • Figure 9. Global Critical Illness Insurance: by Gender USD Million (2017-2022)
  • Figure 10. Global Critical Illness Insurance: by Provider USD Million (2017-2022)
  • Figure 11. South America Critical Illness Insurance Share (%), by Country
  • Figure 12. Asia Pacific Critical Illness Insurance Share (%), by Country
  • Figure 13. Europe Critical Illness Insurance Share (%), by Country
  • Figure 14. MEA Critical Illness Insurance Share (%), by Country
  • Figure 15. North America Critical Illness Insurance Share (%), by Country
  • Figure 16. Global Critical Illness Insurance share by Players 2022 (%)
  • Figure 17. Global Critical Illness Insurance share by Players (Top 3) 2022(%)
  • Figure 18. Global Critical Illness Insurance share by Players (Top 5) 2022(%)
  • Figure 19. BCG Matrix for key Companies
  • Figure 20. China Life Insurance Company (China) Revenue, Net Income and Gross profit
  • Figure 21. China Life Insurance Company (China) Revenue: by Geography 2022
  • Figure 22. Ping An Insurance (China) Revenue, Net Income and Gross profit
  • Figure 23. Ping An Insurance (China) Revenue: by Geography 2022
  • Figure 24. China Pacific Insurance (China) Revenue, Net Income and Gross profit
  • Figure 25. China Pacific Insurance (China) Revenue: by Geography 2022
  • Figure 26. Aviva (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Aviva (United Kingdom) Revenue: by Geography 2022
  • Figure 28. Legal & General (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Legal & General (United Kingdom) Revenue: by Geography 2022
  • Figure 30. New China Life Insurance (China) Revenue, Net Income and Gross profit
  • Figure 31. New China Life Insurance (China) Revenue: by Geography 2022
  • Figure 32. AXA (France) Revenue, Net Income and Gross profit
  • Figure 33. AXA (France) Revenue: by Geography 2022
  • Figure 34. Prudential plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Prudential plc (United Kingdom) Revenue: by Geography 2022
  • Figure 36. Aegon NV (Netherland) Revenue, Net Income and Gross profit
  • Figure 37. Aegon NV (Netherland) Revenue: by Geography 2022
  • Figure 38. Allianz SE (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Allianz SE (Germany) Revenue: by Geography 2022
  • Figure 40. AIG (United States) Revenue, Net Income and Gross profit
  • Figure 41. AIG (United States) Revenue: by Geography 2022
  • Figure 42. UnitedHealthcare Group (United States) Revenue, Net Income and Gross profit
  • Figure 43. UnitedHealthcare Group (United States) Revenue: by Geography 2022
  • Figure 44. Zurich Insurance Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 45. Zurich Insurance Group (Switzerland) Revenue: by Geography 2022
  • Figure 46. MetLife (United States) Revenue, Net Income and Gross profit
  • Figure 47. MetLife (United States) Revenue: by Geography 2022
  • Figure 48. Dai-ichi Life Group (Japan) Revenue, Net Income and Gross profit
  • Figure 49. Dai-ichi Life Group (Japan) Revenue: by Geography 2022
  • Figure 50. Global Critical Illness Insurance: by Type USD Million (2023-2028)
  • Figure 51. Global Critical Illness Insurance: by Application USD Million (2023-2028)
  • Figure 52. Global Critical Illness Insurance: by Policy Type USD Million (2023-2028)
  • Figure 53. Global Critical Illness Insurance: by Premium Mode USD Million (2023-2028)
  • Figure 54. Global Critical Illness Insurance: by Age Group USD Million (2023-2028)
  • Figure 55. Global Critical Illness Insurance: by Gender USD Million (2023-2028)
  • Figure 56. Global Critical Illness Insurance: by Provider USD Million (2023-2028)
  • Figure 57. South America Critical Illness Insurance Share (%), by Country
  • Figure 58. Asia Pacific Critical Illness Insurance Share (%), by Country
  • Figure 59. Europe Critical Illness Insurance Share (%), by Country
  • Figure 60. MEA Critical Illness Insurance Share (%), by Country
  • Figure 61. North America Critical Illness Insurance Share (%), by Country
List of companies from research coverage that are profiled in the study
  • China Life Insurance Company (China)
  • Ping An Insurance (China)
  • China Pacific Insurance (China)
  • Aviva (United Kingdom)
  • Legal & General (United Kingdom)
  • New China Life Insurance (China)
  • AXA (France)
  • Prudential plc (United Kingdom)
  • Aegon NV (Netherland)
  • Allianz SE (Germany)
  • AIG (United States)
  • UnitedHealthcare Group (United States)
  • Zurich Insurance Group (Switzerland)
  • MetLife (United States)
  • Dai-ichi Life Group (Japan)
Additional players considered in the study are as follows:
Huaxia life Insurance (China) , Aflac (United States) , Liberty Mutual (United States) , HCF (Australia) , Religare (India) , Reliance (India) , Manipalcigna Health Insurance Company (India) , Edelwiess (India) , ICICI Prudential Life Insurance Co. Ltd. (India)
Select User Access Type

Key Highlights of Report


Jun 2023 248 Pages 69 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Critical Illness Insurance Quantitative research analysis
Global Critical Illness Insurance Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Critical Illness Insurance market are China Life Insurance Company (China), Ping An Insurance (China), China Pacific Insurance (China), Aviva (United Kingdom), Legal & General (United Kingdom), New China Life Insurance (China), AXA (France), Prudential plc (United Kingdom), Aegon NV (Netherland), Allianz SE (Germany), AIG (United States), UnitedHealthcare Group (United States), Zurich Insurance Group (Switzerland), MetLife (United States) and Dai-ichi Life Group (Japan).
In this highly competitive & fast evolving Critical Illness Insurance industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Heart attack, Life-threatening cancer, Loss of hearing, Loss of speech, Loss of vision, Major organ transplant, Paralysis, Coma, Renal failure, Stroke, Carcinoma in situ, Coronary artery bypass graft and Others are the potential customers of Critical Illness Insurance industry.

Know More About Global Critical Illness Insurance Report?

Have a Query? Click Here

Other Related Reports

Private health insurance Comprehensive Study by Type (Hospital treatment, General treatment, Others), Demographics (Minors, Adults, Senior Citizens), Health Insurance (Hospital treatment, General tr...
$ 3650
Life Insurance Comprehensive Study by Type (Term Life, Whole Life, Universal Life), Application (Residential, Travel, Others) Players and Region - Global Market Outlook to 2028
$ 3500
Health and Medical Insurance Comprehensive Study by Type (Disease Insurance, Medical Insurance), Application (Public Sector, Private Sector, Stand-alone Insurers), Insurance Provider (Hospital, Agent...
$ 3450
Teenager Life Insurance Comprehensive Study by Type (Survival Insurance, Death Insurance, Full Insurance), Policy (Child Rider, Term Policy, Permanent Policy), Age Group (<10 Years Old, 10~18 Years O...
$ 3450
Juvenile Life Insurance Comprehensive Study by Type (Term Life insurance, Whole Life insurance, Universal Life insurance, Variable Life Insurance), Application (School, Home Use), Premium Type (Month...
$ 3500
Short Term Health Insurance Comprehensive Study by End users (Individuals, Corporate, Others), Service providers (Public health insurance providers, Private health insurance providers), Coverage (Inp...
$ 3650